Hepatic drug-metabolizing activities in rats after 14 days of oral administration of the human immunodeficiency virus-type 1 protease inhibitor ritonavir (ABT-538).
作者信息
Kumar G N, Grabowski B, Lee R, Denissen J F
机构信息
Department of Biotransformation, Abbott Laboratories, Abbott Park, IL 60064-3500, USA.
出版信息
Drug Metab Dispos. 1996 May;24(5):615-7.
PMID:8723745
Abstract
摘要
Zotero 插件